AH-HA Tool in the EPIC EHR for Prostate Cancer

Phase-Based Progress Estimates
Virginia Commonwealth University/Massey Cancer Center, Richmond, VAProstate Cancer+5 MoreAH-HA Tool in the EPIC EHR - Other
All Sexes
What conditions do you have?

Study Summary

This trial is looking at the effects of a tool that uses electronic health records to help cancer survivors manage their cardiovascular health. The study will compare how well the tool works compared to usual care in terms of risk reduction and health promotion activities.

Eligible Conditions
  • Prostate Cancer
  • Hodgkin's Lymphoma
  • Breast Cancer
  • Endometrial Cancer
  • Non-Hodgkin's Lymphoma
  • Colorectal Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 8 Secondary · Reporting Duration: 1 year

1 year
CVH behaviors recorded in the past year
CVH factors recorded in the past year
Completed visits with primary care providers and cardiology
Number of CVH-relevant labs and treatments to manage CV risk
Number of referrals to primary care and cardiology to manage CV risk
Proportion of survivors for whom AH-HA is utilized
Measure of tool acceptability with Tool Assessment
Proportion of patients reporting at least one non-ideal or missing CVH topic
Year 1
Patient perception and knowledge of CV risks

Trial Safety

Trial Design

2 Treatment Groups

Usual Care
1 of 2
Intervention - AH-HA tool
1 of 2

Active Control

Experimental Treatment

645 Total Participants · 2 Treatment Groups

Primary Treatment: AH-HA Tool in the EPIC EHR · No Placebo Group · N/A

Intervention - AH-HA tool
Experimental Group · 1 Intervention: AH-HA Tool in the EPIC EHR · Intervention Types: Other
Usual CareNoIntervention Group · 1 Intervention: Usual Care · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,167 Previous Clinical Trials
41,167,910 Total Patients Enrolled
539 Trials studying Prostate Cancer
503,006 Patients Enrolled for Prostate Cancer
University of Texas Southwestern Medical CenterOTHER
962 Previous Clinical Trials
1,107,842 Total Patients Enrolled
16 Trials studying Prostate Cancer
2,135 Patients Enrolled for Prostate Cancer
Washington University School of MedicineOTHER
1,826 Previous Clinical Trials
2,283,752 Total Patients Enrolled
18 Trials studying Prostate Cancer
7,533 Patients Enrolled for Prostate Cancer
Wake Forest University Health SciencesLead Sponsor
1,151 Previous Clinical Trials
1,053,088 Total Patients Enrolled
21 Trials studying Prostate Cancer
1,798 Patients Enrolled for Prostate Cancer
Kathryn Weaver, MDPrincipal InvestigatorWake Forest University Health Sciences

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any available slots left in this research project?

"Clinicaltrials.gov affirms that this particular medical trial is no longer recruiting patients at the present time, having been initially listed on October 1st 2020 and most recently updated November 3rd 2022. However, 7027 other trials are actively searching for participants right now." - Anonymous Online Contributor

Unverified Answer

How widespread is this medical trial across the state?

"11 prospective clinical trial centres are currently signing up patients. These sites span cities such as Saint Louis, Scranton and Appleton among 11 other locales. It is advised that you select the closest clinic to your location in order to reduce travelling requirements should you choose to join this study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.